TY - CHAP M1 - Book, Section TI - Neuroendocrine Tumors A1 - Ekeblad, Sara A1 - Skogseid, Britt A2 - Boyiadzis, Michael M. A2 - Fojo, Tito PY - 2022 T2 - Hematology-Oncology Therapy, 3e AB - EpidemiologyTable Graphic Jump Location|Download (.pdf)|PrintEpidemiologyIncidence:1/100,000 ~85% sporadic~15% hereditary, for example, multiple endocrine neoplasia (MEN1), von Hippel-Lindau diseaseMedian age:53–57 yearsMale to female ratio:0.8–1.3:1Ekeblad SB et al. Clin Cancer Res 2008;14:7798–7803Fischer L et al. Br J Surg 2008;95:627–635Hochwald SN et al. J Clin Oncol 2002;20:2633–2642Öberg K, Eriksson B. Best Pract Res Clin Gastroenterol 2005;19:753–781Tomassetti PD et al. Ann Oncol 2005;16:1806–1810 SN - PB - McGraw-Hill Education CY - New York, NY Y2 - 2024/03/29 UR - hemonc.mhmedical.com/content.aspx?aid=1187883666 ER -